Effects of Fixation Technique On Thoracic Epidural Catheter Displacement
Launched by UNIVERSITY OF UTAH · Jun 4, 2019
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well different methods of securing a thoracic epidural catheter (a small tube placed in the back to deliver pain relief) work. The researchers want to compare a newer method called Dermabond with two commonly used methods, Mastisol and the Grip-Lok bandage. The goal is to see which method keeps the catheter in place better, helping to improve patient comfort and care.
To participate in this study, you need to be an adult (18 years or older) who is having surgery and receiving a thoracic epidural. However, if you have allergies to adhesives or local anesthesia, are pregnant, or have certain medical conditions that prevent you from receiving an epidural, you won't be eligible. If you join the trial, you can expect to receive one of the three fixation methods and help researchers learn more about the best way to secure epidurals. The study is currently looking for participants, and everyone is welcome, regardless of gender. Your involvement could help improve pain management for future patients!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • surgical patient
- • receiving a thoracic epidural
- • 18 years of age or older
- Exclusion Criteria:
- • Patient refusal
- • allergy to adhesives or local anesthesia
- • pregnancy
- • contraindication to receiving an epidural including coagulopathy, infection, elevated ICP, or severe pre-existing neurologic disorders
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials